Holen Sie sich die Stockscreener-App
0.821
0.02%
-0.0091
Schlusskurs vom Vortag:
$0.8301
Offen:
$0.822
24-Stunden-Volumen:
2,419
Relative Volume:
0.03
Marktkapitalisierung:
$38.87M
Einnahmen:
$10.85M
Nettoeinkommen (Verlust:
$-51.31M
KGV:
-1.114
EPS:
-0.737
Netto-Cashflow:
$-40.15M
1W Leistung:
-1.23%
1M Leistung:
+12.03%
6M Leistung:
-49.70%
1J Leistung:
-66.26%
1-Tages-Spanne:
$0.822
$0.8498
1-Wochen-Bereich:
$0.81
$0.8998
52-Wochen-Spanne:
$0.63
$2.565
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
0.8299 | 38.88M | 10.85M | -51.31M | -40.15M | -0.737 |
ABT
Abbott Laboratories
|
106.17 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.62 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.14 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.80 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.53 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-02 | Eingeleitet | Maxim Group | Buy |
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD announces inducement grants - Medical Buyer
Inspiremd Stock Price Forecast. Should You Buy NSPR? - StockInvest.us
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Inc. (NSPR) Key Financial Ratios – Valuation, Profitability & More - Value Research
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - Value Research
InspireMD Inc. Series B Warrants (NSPRZ) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
InspireMD Inc. Series B Warrants (NSPRZ) Peer Comparison – Compare with Others - Value Research
InspireMD Earnings Call: Recall Pain, Regulatory Potential - TipRanks
InspireMD Inc. Series B Warrants (NSPRZ) Key Financial Ratios – Valuation, Profitability & More - Value Research
InspireMD (NSPR) Drops 4.65% to $0.89 as Key Support at $0.85 Comes into FocusETF Creation Redemption - siam.in
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
InspireMD Q2 2026 Earnings: Revenue Misses $1.77 Million Estimate - Sci-Tech Today
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $4 - Moomoo
InspireMD total revenue down 0.4% to USD 1,771,000 in Q2 2026 - Medical Buyer
Form 8K InspireMD Inc For: 17 August By Investing.com - Investing.com South Africa
InspireMD Q2 revenue holds at $1.8 million - grafa.com
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com Nigeria
InspireMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
symbol__ Stock Quote Price and Forecast - CNN
InspireMD reports Q2 2026 revenue $1.77M, net loss $14.3M; cash & marketable securities $30.4M - TradingView
InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss - Quiver Quantitative
InspireMD (NSPR) recall turns U.S. sales negative — and deepens quarterly loss - Stock Titan
InspireMD Q2 Operating Expenses USD 13.671 Mi - Moomoo
InspireMD Reports Second Quarter 2026 Financial Results - The Manila Times
InspireMD (NSPR) Surges 16.97% to $0.98, Pushing Toward Key ResistanceSentiment Shift - vinanet.vn
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Moomoo
InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk - Stock Titan
InspireMD Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
NSPR|InspireMD Inc|Price:0.900| - TradingKey
InspireMD (NSPR) Dips 3.26% to $0.83, Pressing Against Key SupportVolatility Smirk - vinanet.vn
InspireMD (NSPR.US) is scheduled to release its financial report on August 17. - Moomoo
InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InspireMD grants 91,161 restricted shares to new employees - scanx.trade
InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set - scanx.trade
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan
Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k - webull.com
InspireMD Approves 221,666 Restricted Shares for New Hire - Stock Titan
InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates - Kalkine
NSPR Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Shares HigherReturn On Equity - vinanet.vn
InspireMD (NSPR) Gains 5.73% to $0.72, Pressing Toward Key Resistance at $0.76BPI Reversal - vinanet.vn
InspireMD (NSPR) Slides 3.68% to $0.65 as Key Support HoldsBullish Pattern Stocks - vinanet.vn
Piper Sandler Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com - Investing.com Nigeria
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):